These findings shared in the media and social media are based on a preprint that has not yet undergone peer review. The intervention evaluated in the EVANTHEA trial is not approved by the U.S. Food and Drug Administration for the treatment, cure, or prevention of Alzheimer’s disease, mild cognitive impairment, or dementia. This summary is provided for scientific and informational purposes only and is not intended as medical advice.